Market Place
Sourcing Support
All News #Library
Others
Arbor Biotechnologies to Participate in the 2022 Cell & Gene Meeting on the Mesa
04 Oct 2022 //
GLOBENEWSWIRE
Lupin receives US FDA approval for generic Edarbi tablets
24 Dec 2021 //
PHARMABIZ
Lupin receives US FDA approval for generic Edarbi tablets
24 Dec 2021 //
PHARMABIZ
Azurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceuticals
24 Aug 2021 //
BIOSPACE
Arbor Pharma presents results from phase 3 study in adults of AR19 to treat ADHD
11 Sep 2020 //
PHARMABIZ
Arbor Presents Data from of AR19, an Investigational ADHD Prescription Stimulant
10 Sep 2020 //
BIOSPACE
Arbor Pharmaceuticals, LLC Confirms Availability of Triptodur® (triptorelin)
25 Aug 2020 //
PRNEWSWIRE
Arbor Pharmaceuticals, LLC Confirms Availability of Triptodur® (triptorelin)
25 Aug 2020 //
PRNEWSWIRE
Arbor Pharmaceuticals Announces FDA Filing Acceptance NDA for AR19
13 May 2020 //
PRNEWSWIRE
CRISPR pioneer Feng Zhang`s upstart biotech seeks $100M
30 Sep 2019 //
ENDPTS
Arbor Pharma taps Shaq as BiDil spokesman
04 Apr 2019 //
FIERCE PHARMA
Arbor & Debiopharm International Announce Commercial Availability of Triptodur
03 Oct 2017 //
PR NEWSWIRE
Arbor Pharmaceuticals, LLC Launches New Nymalize® (nimodipine) Oral Solution
20 Sep 2017 //
PR NEWSWIRE
Arbor & Debiopharm Announce U.S. FDA Approval for Triptodur™, Triptorelin 6-month Formulation
01 Jul 2017 //
PR NEWSWIRE
When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price
20 Jan 2017 //
PROPUBLICA
Laboratorios SALVAT & Arbor Pharmaceuticals, LLC Announce the Launch of OTOVEL
29 Aug 2016 //
PR NEWSWIRE
Arbor Pharma Shells Out $467 Million for Bay Area’s Restless Leg Drug Company
23 May 2016 //
BIOSPACE
Debiopharm,Arbor Announce Their US Commercialization Partnership for Triptorelin
11 Jan 2016 //
PR NEWS WIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.